Glassmedical
This company develops predictive AI technology to accelerate oncology drug development and improve clinical trial efficiency. Their pipelines enable pharmaceutical and biotech partners to achieve smarter patient stratification and study design for cancer therapies. This focus aims to reduce development risk and deliver effective treatments to patients faster.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops predictive AI technology to accelerate oncology drug development and improve clinical trial efficiency. Their pipelines enable pharmaceutical and biotech partners to achieve smarter patient stratification and study design for cancer therapies. This focus aims to reduce development risk and deliver effective treatments to patients faster.